Cargando…
RF32 | PSUN58 BIO89-100 Treatment Ameliorates a Subclinical Increase in Spleen Volume in Non-cirrhotic NASH in Correlation With Change in Liver Fat, HOMA-IR and Inflammatory Markers in a Phase 1b/2a, Placebo-Controlled, Double-Blind Proof of Concept Study
BACKGROUND AND AIMS: Portal venous pressure may begin to rise due to steatosis-induced changes in sinusoidal homeostasis in early stages of NASH and may contribute to progression of fibrosis and portal hypertension1. FGF21 is an endogenous hormone regulating carbohydrate, lipid and energy metabolism...
Autores principales: | Frias, Juan, Johansson, Lars, Will Charlton, R, Feng, Shibao, Agollah, Germaine D, Mansbach, Hank, Margalit, Maya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624706/ http://dx.doi.org/10.1210/jendso/bvac150.535 |
Ejemplares similares
-
Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?
por: Khalili, Davood, et al.
Publicado: (2023) -
BIO89-100 Demonstrated Robust Reductions in Liver Fat and Liver Fat Volume (LFV) by MRI-PDFF, Favorable Tolerability and Potential for Weekly (QW) or Every 2 Weeks (Q2W) Dosing in a Phase 1b/2a Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in NASH
por: Frias, Juan Pablo, et al.
Publicado: (2021) -
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018) -
Prevalence of insulin resistance and identifying HOMA1-IR and HOMA2-IR indexes in the Middle Black Sea region of Turkey
por: Demir, Ayşe Kevser, et al.
Publicado: (2020) -
The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS)
por: Vilela, Brunna Sullara, et al.
Publicado: (2016)